Screen‐Detected Coeliac Disease in a Nationally Representative Cohort: Health Indicators, Long‐Term Outcomes and Mortality
Open Access
- 10 August 2026
- journal article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 64 (9) , 1248-1259
Abstract
Background: Population‐based screening for coeliac disease could reduce underdiagnosis, but benefits and harms remain debated. Aim: We studied health outcomes in screen‐detected coeliac disease patients at diagnosis and following a long‐term gluten‐free diet. Methods: Data were collected from Health 2000 and 2011 studies representing the Finnish population. Coeliac disease was screened in 6339 individuals by transglutaminase and endomysial antibodies, with dual seropositivity as the diagnostic criterion, histologically validated in this cohort. Survey‐weighted analyses enabled population‐level results. The follow‐up cohort comprised those participating in both time points. Mortality was assessed between 2000 and 2017. Results: At screening, 92 (1.5%) undiagnosed coeliac disease patients and 6216 non‐coeliac controls were identified. Patients were less often smokers (11% vs. 22%, p = 0.014), more often had a history of pre‐eclampsia (13% vs. 5%, p = 0.037) and anaemia (14% vs. 6%, p = 0.012), and lower ferritin (29 vs. 68 ng/mL, p < 0.001), with an altered lipid profile including lower total cholesterol, LDL‐C, and ApoB but higher atherogenic ratios. At 11‐year follow‐up, mental health, quality of life, and cardiometabolic markers were comparable between treated coeliac disease patients ( n = 50) and non‐coeliac controls ( n = 3226). Mortality did not differ after adjustment for age and sex (HR 0.77, 95% CI 0.45–1.33). Conclusions: Nationally screened adults with undiagnosed coeliac disease showed iron deficiency and anaemia. Long‐term dietary treatment did not adversely affect quality of life or cardiometabolic health and may prevent complications. Furthermore, mortality was comparable to the general population. The results suggest a favourable benefit‐harm balance for population‐based screening.Keywords
Funding Information
- Tays
- Lastentautien Tutkimussäätiö
- Päivikki ja Sakari Sohlbergin Säätiö
- Emil Aaltosen Säätiö
- Suomen Lääketieteen Säätiö (7850)
- Research Council of Finland
- Suomen Kulttuurirahasto
- Sigrid Juséliuksen Säätiö
This publication has 50 references indexed in Scilit:
- European Society for the Study of Coeliac Disease 2025 Updated Guidelines on the Diagnosis and Management of Coeliac Disease in Adults. Part 1: Diagnostic ApproachUnited European Gastroenterology Journal, 2025
- One-Year Outcomes Among Children Identified With Celiac Disease Through a Mass Screening ProgramClinical Gastroenterology and Hepatology, 2024
- Cancer Risk in 47,241 Individuals With Celiac Disease: A Nationwide Cohort StudyClinical Gastroenterology and Hepatology, 2022
- The prevalence of celiac disease in women with infertility—A systematic review with meta‐analysisReproductive Medicine and Biology, 2021
- Global Prevalence of Celiac Disease: Systematic Review and Meta-analysisClinical Gastroenterology and Hepatology, 2018
- Celiac disease and obstetric complications: a systematic review and metaanalysisAmerican Journal of Obstetrics and Gynecology, 2016
- Celiac disease from a global perspectiveBest Practice & Research Clinical Gastroenterology, 2015
- Diet Improves Perception of Health and Well-being in Symptomatic, but Not Asymptomatic, Patients With Celiac DiseaseClinical Gastroenterology and Hepatology, 2011
- Predictors of Family Risk for Celiac Disease: A Population-Based StudyClinical Gastroenterology and Hepatology, 2008
- Change in Lipid Profile in Celiac Disease: Beneficial Effect of Gluten-Free DietThe American Journal of Medicine, 2006